Persistence to Antihypertensive and Clinical Outcomes in Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention

Kristin, Erna and Dinarti, Lucia Kris and Febrinasari, Ratih Puspita and Pratiwi, Woro Rukmi and Yasmina, Alfi and Jaya, Sudi Indra (2023) Persistence to Antihypertensive and Clinical Outcomes in Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention. Indonesian Journal of Pharmacy, 34 (3). 482 – 490. ISSN 23389427

[thumbnail of Kristin_KU.pdf] Text
Kristin_KU.pdf - Published Version
Restricted to Registered users only

Download (601kB) | Request a copy

Abstract

Acute coronary syndrome (ACS) is a life-threatening condition that carries a high risk of recurrent cardiovascular events and death. Persistence to treatment is known to reduce disease morbidity and mortality in patients with ACS. In this study, we focus on ACS patients undergoing their first percutaneous coronary intervention (PCI) to investigate the association between persistence to antihypertensive therapy and clinical outcomes. A retrospective cohort study with two years of follow-up was conducted with 367 patients recruited. Patients were deemed as having the persistence to antihypertensive therapy (WHO ATC Code C02, C03, C07, C08, C09) if the gap between prescriptions was ≤ 30 days. The clinical outcomes were defined as a composite of major adverse cardiac events (MACE), major adverse cardiovascular and cerebrovascular events (MACCE), myocardial infarction, recurrent PCI, stroke, all-cause death, cardiovascular death, and hospitalization. Cumulative persistence to antihypertensive showed 72.3 of ACS patients still taking antihypertensive one year after PCI. Persistence to treatment with antihypertensive therapy can be used as a predictor of MACE or MACCE because it was associated with recurrent PCI (RR 1.94, 95 CI = 1.02-3.71). Our study indicates that among ACS patients undergoing their first PCI, non-persistence to antihypertensive therapy may lead to worse clinical outcomes. This data will be useful in promoting secondary prevention in ACS patients after PCI. Copyright © 2023 by Indonesian Journal of Pharmacy (IJP)

Item Type: Article
Additional Information: Cited by: 0
Uncontrolled Keywords: antihypertensive agent; beta adrenergic receptor blocking agent; calcium channel blocking agent; acute coronary syndrome; adult; antihypertensive therapy; Article; cause of death; cerebrovascular accident; cerebrovascular disease; clinical assessment; clinical outcome; cohort analysis; controlled study; disease association; female; follow up; heart infarction; hospitalization; human; hypertension; major adverse cardiac event; major clinical study; male; middle aged; outcome assessment; percutaneous coronary intervention; prescription; recurrent disease; retrospective study; secondary prevention
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Faculty of Medicine, Public Health and Nursing > Nursing
Depositing User: Sri JUNANDI
Date Deposited: 30 Oct 2024 13:45
Last Modified: 30 Oct 2024 13:45
URI: https://ir.lib.ugm.ac.id/id/eprint/6022

Actions (login required)

View Item
View Item